{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:55:00Z","timestamp":1790074500978,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1991,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Association of Cancer Research"},{"name":"Sacred Heart Catholic University of Rome"},{"name":"Nadia Salcini Foundation"},{"name":"Associazione per il progresso della terapia intensiva onocematologica"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jmoldx.2014.03.003","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T16:18:03Z","timestamp":1399652283000},"page":"467-476","source":"Crossref","is-referenced-by-count":18,"title":["Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker"],"prefix":"10.1016","volume":"16","author":[{"given":"Manuela","family":"Giachelia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bozzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"D'Al\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Tisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Massini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Maiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cupelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi M.","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Voso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hohaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2014.03.003_bib1","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib2","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project","volume":"27","author":"Federico","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib3","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2008-05-154013","article-title":"The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival","volume":"112","author":"O'Shea","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3109\/10428194.2012.753445","article-title":"High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature","volume":"54","author":"Herold","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12032-012-0441-3","article-title":"Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma","volume":"30","author":"Krajnovi\u0107","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10428194.2010.531412","article-title":"Gene expression profiling in follicular lymphoma and its implication for clinical practice","volume":"52","author":"Janikova","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib7","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2004-06-2490","article-title":"Quantitative PCR of bone marrow BCL2\/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma","volume":"105","author":"Rambaldi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.bmt.1702147","article-title":"Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation","volume":"25","author":"Hirt","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0301-472X(00)00651-2","article-title":"A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex\u00a0vivo purging in follicular lymphoma patients","volume":"29","author":"Ladetto","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood.V98.4.940","article-title":"Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma","volume":"98","author":"Mandigers","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12032-008-9071-1","article-title":"Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma","volume":"26","author":"Paszkiewicz-Kozik","year":"2009","journal-title":"Med Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib12","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2003-10-3411","article-title":"Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule","volume":"103","author":"Ghielmini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib13","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.2009.25.0852","article-title":"BCL-2\/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed\/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study","volume":"28","author":"van Oers","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib14","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1182\/blood.V93.9.3081.409a43_3081_3087","article-title":"Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma","volume":"93","author":"L\u00f3pez-Guillermo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2141.2008.07101.x","article-title":"Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients","volume":"141","author":"Hirt","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib16","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2002-02-0621","article-title":"High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"100","author":"Ladetto","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib17","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","article-title":"Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma","volume":"94","author":"Freedman","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1182\/blood.V94.5.1773","article-title":"Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas","volume":"94","author":"Baur","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib19","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1182\/blood-2001-11-0026","article-title":"Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype","volume":"100","author":"Li","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib20","first-page":"154","article-title":"Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia","volume":"89","author":"Rossi","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib21","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/leu.2009.114","article-title":"Array-based DNA methylation profiling in follicular lymphoma","volume":"23","author":"O'Riain","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib22","first-page":"1252","article-title":"DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma","volume":"91","author":"Voso","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib23","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1158\/0008-5472.CAN-06-1681","article-title":"DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia","volume":"67","author":"Agrawal","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib24","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1182\/blood-2008-02-141002","article-title":"Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia","volume":"113","author":"Yang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.leukres.2009.06.028","article-title":"Aberrant DNA methylation of the p57KIP2 gene is a sensitive biomarker for detecting minimal residual disease in diffuse large B cell lymphoma","volume":"34","author":"Hagiwara","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1158\/1078-0432.CCR-11-0849","article-title":"Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma","volume":"18","author":"Stutterheim","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib27","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib28","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1210\/jc.2005-0313","article-title":"Quantitative assessment of promoter methylation profiles in thyroid neoplasms","volume":"90","author":"Hoque","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","article-title":"Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib30","first-page":"7694","article-title":"Death-associated protein kinase promoter hypermethylation in normal human lymphocytes","volume":"63","author":"Reddy","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib31","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","article-title":"Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte","volume":"15","author":"Brice","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib32","doi-asserted-by":"crossref","first-page":"E138","DOI":"10.1002\/ijc.26429","article-title":"Quantitative analyses of DAPK1 methylation in AML and MDS","volume":"131","author":"Claus","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.leu.2404535","article-title":"Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cca.2012.01.013","article-title":"Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer","volume":"413","author":"Yao","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1046-2023(02)00062-2","article-title":"Conversion-specific detection of DNA methylation using real-time polymerase chain reaction (ConLight-MSP) to avoid false positives","volume":"27","author":"Rand","year":"2002","journal-title":"Methods"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib36","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/cncr.20568","article-title":"The clinical value of tumor burden at diagnosis in Hodgkin lymphoma","volume":"101","author":"Gobbi","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MNM.0b013e3282f813a4","article-title":"Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET","volume":"29","author":"Berkowitz","year":"2008","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","article-title":"Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial","volume":"377","author":"Salles","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/jnci\/djr450","article-title":"Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis","volume":"104","author":"Al Khabori","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib40","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1200\/JCO.2010.33.4474","article-title":"Watchful waiting in low-tumor burden follicular lymphoma in the rituximab era: results of an F2-study database","volume":"30","author":"Solal-C\u00e9ligny","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2014.03.003_bib41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/PPO.0b013e31826aed4f","article-title":"Has single-agent rituximab replaced watch-and-wait for a patient with asymptomatic low-grade follicular lymphoma?","volume":"18","author":"Lowry","year":"2012","journal-title":"Cancer J"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157814000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157814000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T12:43:02Z","timestamp":1576240982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157814000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1525157814000701"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2014.03.003","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}